Industry News

At the recently concluded 2023 International Diabetes Congress, GLP-1 receptor agonists (GLP-1 RAs) emerged as the central theme, with experts and scholars highlighting their transformative role in diabetes management, obesity treatment, and beyond-metabolic health benefits. As a leading GLP-1 drug wholesaler, Vetion synthesizes key insights from the congress to showcase why these therapies are reshaping […]

August 26, 2023 – The latest industry research report shows that the GLP-1 drug market is growing at an average annual rate of 35%, and the global GLP-1 receptor agonist (GLP-1 RA) market has emerged as one of the most dynamic sectors in pharmaceuticals, with **2023 sales reaching 20 billion. Driven by groundbreaking efficacy in